PHILAB Industries Inc., subsidiary of health sciences firm Philab Holdings Corp. (PSE:DNA), has recently announced its partnership with My Doctor Now (MyDocNow) that will reach out to the rural and underserved communities in the country through remote diagnostics and treatment, further strengthening Philab’s goal in providing access to healthcare services for over 100 million Filipinos.
Initially launched in the Philippines last 2016, MyDocNow is an organization of medical and health professionals dedicated to widening healthcare options through virtual healthcare delivery.
The 24/7 telemedicine platform is meant to conveniently connect patients and physicians for emergency care.
“It is crucial to efficiently deliver the best possible treatment to everyone. With the help of telemedicine technology, we are addressing the challenge of reaching out to the underserved communities in need of equal medical attention,” said Tom Navasero, chairman and president of Philab Holdings Inc.
Telemedicine is known as the use of a mobile device and internet that seamlessly provides communication between doctors and patients. Its real-time services include video consultations with doctors, comprehensive patient education and remote monitoring through a smartphone device.
Additionally, it offers delivery of prescriptions, medication, lab results and doctor or nurse home visits 24/7 in selected areas.
“We are committed in bringing this telemedicine platform around the country with the goal to provide a more efficient way for patients and doctors alike to receive and provide quality services. The presence of telemedicine technology removes the inconvenience and costs for both doctors and patients when it comes to traveling and distance,” said Dr. Mike Vergara, chief medical officer of MyDocNow.
Through this partnership, Philab and MyDocNow envision a future wherein even patients in rural areas can easily consult with medical experts without going through the trouble of traveling for hours.
“Immediate attention from a medical professional is fundamental, most especially when it comes to patients who are seeking for urgent treatment. Right now, the rapid progress of technology is on our side and we must fully utilize it in order to continuously provide convenience and accessible healthcare solutions to the public,” Navasero added.
Established in 1958, Philab has been present in the life sciences and healthcare industry for over 59 years. The company supplies life science equipment, designs and builds laboratories, distributes in-vitro diagnostics (IVD) tools and now invests on new business ventures focused on genomics.